What’s on: AIDS 2020 Virtual for treatment activists
NewsKicking off on Monday 6 July, with a workshop on innovative strategies to reduce prohibitive drug prices, we’ve compiled some...
Read more about What’s on: AIDS 2020 Virtual for treatment activists
Ukraine: 100% LIFE opposes patent on TB drug for children
NewsOur campaign partner in Ukraine, 100% LIFE, has submitted the first patent opposition on bedaquiline in the Eastern Europe and Central...
Read more about Ukraine: 100% LIFE opposes patent on TB drug for children
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Call to action NewsOur partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
Read more about Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
COVID-19: Local manufacturing essential if we are to “treat all”
NewsITPC led a virtual roundtable last week (26 May 2020) attended by civil society treatment experts, researchers, and national pharmaceutical...
Read more about COVID-19: Local manufacturing essential if we are to “treat all”
Moroccan civil society calls for compulsory licence on Gilead’s possible COVID-19 drug
NewsOn 12 May 2020, Gilead Sciences announced voluntary licenses to five generic manufacturers in India and Pakistan allowing them to...
Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
NewsBedaquiline (BDQ) is a core component of an ‘all-oral’ solution to multi-drug resistant TB (MDR-TB), and is recommended by the...
Read more about Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
Civil society asks WHO and Unitaid to ensure equitable access to COVID-19 technologies – and that commitment is binding
Call to action NewsIn an open letter, sent to Unitaid, the World Health Organization (WHO) and its Member States today, 86 civil society...
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
Call to action NewsAbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
COVID-19 pandemic: ‘An opportunity of a lifetime’?
News Research The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
Read more about COVID-19 pandemic: ‘An opportunity of a lifetime’?
Global headlines: Potential COVID-19 drugs are over-priced
News ResearchFrom the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...
Read more about Global headlines: Potential COVID-19 drugs are over-priced